Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene therapy patients monitored for 15 years in safety study

NCT ID NCT01492036

First seen Jan 09, 2026 · Last updated Apr 30, 2026 · Updated 18 times

Summary

This study follows people who have received gene transfer therapy for cancer or other conditions. Researchers want to learn about any long-term side effects or benefits over 15 years. Participants include up to 130 patients from MD Anderson Cancer Center. The goal is to build a database to improve future gene therapy safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.